Found 371 with Last Name = 'reichart' and Initial = 'f' 
Affinity DataIC50: 0.0600nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.0600nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.210nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.260nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.260nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.540nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.540nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
Affinity DataIC50: 0.670nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.670nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta6 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.790nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.910nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 0.910nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Division Of Organic Chemistry Csir-National Chemical Laboratory (Ncl)
Curated by ChEMBL
Division Of Organic Chemistry Csir-National Chemical Laboratory (Ncl)
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of fibrinogen binding to human platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
3D Structure (crystal)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 1.20nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 1.40nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 1.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.60nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 1.70nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 1.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.20nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 2.80nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 3.30nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.70nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 4.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.5nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.5nMAssay Description:Inhibition of vitronectin binding to human alphaVbeta3 integrin after 1 hr by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 5.5nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
Affinity DataIC50: 5.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.80nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.40nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.40nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7.30nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Division Of Organic Chemistry Csir-National Chemical Laboratory (Ncl)
Curated by ChEMBL
Division Of Organic Chemistry Csir-National Chemical Laboratory (Ncl)
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta5 (Gly24 to Asn719 residues) expressed in CHO c...More data for this Ligand-Target Pair
Affinity DataIC50: 8.10nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8.10nMAssay Description:Inhibition of LAP binding to human integrin alphavbeta8 receptor after 1 hr by solid-phase binding assayMore data for this Ligand-Target Pair
